ORGANIZATION AND DESCRIPTION OF BUSINESS (Details) - Endo [Member] - USD ($)	1 Months Ended
	Feb. 29, 2016	Jun. 30, 2019	Feb. 01, 2016
Organization and Description of Business [Abstract]
Deferred revenue			$ 8,250,000
Proceeds from licensing agreement	$ 8,250,000
Opt-in fee receivable for each indication		$ 500,000
Regular opt-in fee receivable for each indication		$ 750,000